300
Participants
Start Date
November 12, 2020
Primary Completion Date
June 1, 2021
Study Completion Date
June 1, 2021
no Intervention
This is an observational study. There is no intervention
Weill Cornell Medical College, New York
University of Pittsburgh Medical Center, Pittsburgh
Ochsner Medical Center, New Orleans
Johns Hopkins Hospital, Baltimore
University of North Carolina at Chapel Hill, Chapel Hill
Emory University, Atlanta
University of Michigan Health System, Ann Arbor
Henry Ford Health System, Detroit
Mayo Clinic, Rochester
The University of Texas Health Science Center at Houston, Houston
University of Colorado Denver, Aurora
Harbor-University of California Los Angeles Medical Center, Torrance
Case Western Reserve University, Cleveland
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Duke University
OTHER